Check out your Company Bowl for anonymous work chats.
1910 Genetics and Microsoft are collaborating to accelerate drug discovery. 1910 will use Microsoft’s Azure Quantum Elements to supercharge its synergistic, dual-purpose, small and large molecule platform that integrates AI, computation, and biological automation to design drug-like molecules better, faster, and cheaper than traditional approaches.
Drug Discovery with 1910 Genetics: Knowing Your Tools (EP 112)
Welcoming 1910 Genetics to the M12 Portfolio
Disrupting the pharmaceutical drug discovery process, 1910 Genetics aims to make drug research much more efficient.
1910 Genetics Debuts with $26M to Accelerate the Design of Small Molecule and Protein Therapeutics Through AI, Computation and Biological Automation
